Drugs / TTI-1612
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01559961 | Mar 2012 → Feb 2013 | interstitial cystitis | Trillium Therapeutics Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TTI-1612 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01559961 ↗ |
| Route | Other | “administered intravesically” NCT01559961 ↗ |